Ayesha Al-Sabah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ayesha Al-Sabah has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Iain Stuart Whitaker
Reconstructive Surgery and Regenerative Medicine Research Centre, Swansea University, Swansea SA2 8PP, UK
12 shared publications Zita M. Jessop
Reconstructive Surgery & Regenerative Medicine Research Group, Institute of Life Science, Swansea University Medical School, Swansea, UK; Welsh Centre for Burns and Plastic Surgery, Morriston Hospital, Swansea, UK
5 shared publications- Karl Hawkins
College of Medicine, Swansea University, Swansea, UK
3 shared publications Z.M. Jessop
Reconstructive Surgery and Regenerative Medicine Research Group, Swansea University Medical School, Swansea, United Kingdom
3 shared publications- Emma Jane Blain
Connective Tissue Biology Laboratories, School of Biosciences, Cardiff University, Cardiff, UK
2 shared publications Emman Combellack
Reconstructive Surgery & Regenerative Medicine Group, Institute of Life Science, Swansea University Medical School, Swansea, UK; The Welsh Centre for Burns and Plastic Surgery, Morriston Hospital, Swansea, UK
2 shared publications
Latest Publications
- Open Access
- 8 July 2019
- Published by IOP Publishing in Biofabrication
- Vol. 11 (4) , 045006
Printability of pulp derived crystal, fibril and blend nanocellulose-alginate bioinks for extrusion 3D bioprinting
One of the main challenges for extrusion 3D bioprinting is the identification of non-synthetic bioinks with suitable rheological properties and biocompatibility. Our aim was to optimize and compare the printability of crystal, fibril and blend formulations of novel pulp derived nanocellulose bioinks and assess biocompatibility with human nasoseptal chondrocytes. The printability of crystalline, fibrillated and blend formulations of nanocellulose was determined by assessing resolution (grid-line assay), post-printing shape fidelity and rheology (elasticity, viscosity and shear thinning characteristics) and compared these to pure alginate bioinks. The optimized nanocellulose-alginate bioink was bioprinted with human nasoseptal chondrocytes to determine cytotoxicity, metabolic activity and bioprinted construct topography. All nanocellulose-alginate bioink combinations demonstrated a high degree of shear thinning with reversible stress softening behavior which contributed to post-printing shape fidelity. The unique blend of crystal and fibril nanocellulose bioink exhibited nano- as well as micro-roughness for cellular survival and differentiation, as well as maintaining the most stable construct volume in culture. Human nasoseptal chondrocytes demonstrated high metabolic activity post printing and adopted a rounded chondrogenic phenotype after prolonged culture. This study highlights the favorable rheological, swelling and biocompatibility properties of nanocellulose-alginate bioinks for extrusion-based bioprinting.
- 8 July 2019
- Published by IOP Publishing in Biofabrication
- Vol. 11 (4) , 045006
Open AccessPrintability of pulp derived crystal, fibril and blend nanocellulose-alginate bioinks for extrusion 3D bioprinting
One of the main challenges for extrusion 3D bioprinting is the identification of non-synthetic bioinks with suitable rheological properties and biocompatibility. Our aim was to optimize and compare the printability of crystal, fibril and blend formulations of novel pulp derived nanocellulose bioinks and assess biocompatibility with human nasoseptal chondrocytes. The printability of crystalline, fibrillated and blend formulations of nanocellulose was determined by assessing resolution (grid-line assay), post-printing shape fidelity and rheology (elasticity, viscosity and shear thinning characteristics) and compared these to pure alginate bioinks. The optimized nanocellulose-alginate bioink was bioprinted with human nasoseptal chondrocytes to determine cytotoxicity, metabolic activity and bioprinted construct topography. All nanocellulose-alginate bioink combinations demonstrated a high degree of shear thinning with reversible stress softening behavior which contributed to post-printing shape fidelity. The unique blend of crystal and fibril nanocellulose bioink exhibited nano- as well as micro-roughness for cellular survival and differentiation, as well as maintaining the most stable construct volume in culture. Human nasoseptal chondrocytes demonstrated high metabolic activity post printing and adopted a rounded chondrogenic phenotype after prolonged culture. This study highlights the favorable rheological, swelling and biocompatibility properties of nanocellulose-alginate bioinks for extrusion-based bioprinting.
- 1 May 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 212, 242-251
Structural and mechanical characterization of crosslinked and sterilised nanocellulose-based hydrogels for cartilage tissue engineering
- 1 May 2019
- Published by Elsevier in Carbohydrate Polymers
- Vol. 212, 242-251
Structural and mechanical characterization of crosslinked and sterilised nanocellulose-based hydrogels for cartilage tissue engineering
- Open Access
- 1 October 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 198, 270-280
Characterization of pulp derived nanocellulose hydrogels using AVAP® technology
- 1 October 2018
- Published by Elsevier in Carbohydrate Polymers
- Vol. 198, 270-280
Open AccessCharacterization of pulp derived nanocellulose hydrogels using AVAP® technology
- 1 May 2018
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 71 (5) , 615-623
Skin tissue engineering using 3D bioprinting: An evolving research field
- 1 May 2018
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 71 (5) , 615-623
Skin tissue engineering using 3D bioprinting: An evolving research field
- 1 January 2018
- Published by Elsevier
- p. 235-244
The clinical need for 3D printed tissue in reconstructive surgery
- 1 January 2018
- Published by Elsevier
- p. 235-244
The clinical need for 3D printed tissue in reconstructive surgery
- 1 September 2017
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 70 (9) , 1155-1170
3D bioprinting for reconstructive surgery: Principles, applications and challenges
- 1 September 2017
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 70 (9) , 1155-1170
3D bioprinting for reconstructive surgery: Principles, applications and challenges
- Top Cited Papers
- 30 May 2017
- Published by Wiley in Advanced Healthcare Materials
- Vol. 6 (16)
‘Printability' of Candidate Biomaterials for Extrusion Based 3D Printing: State‐of‐the‐Art
Regenerative medicine has been highlighted as one of the UK's 8 ‘Great Technologies' with the potential to revolutionize patient care in the 21st Century. Over the last decade, the concept of ‘3D bioprinting' has emerged, which allows the precise deposition of cell laden bioinks with the aim of engineering complex, functional tissues. For 3D printing to be used clinically, there is the need to produce advanced functional biomaterials, a new generation of bioinks with suitable cell culture and high shape/print fidelity, to match or exceed the physical, chemical and biological properties of human tissue. With the rapid increase in knowledge associated with biomaterials, cell‐scaffold interactions and the ability to biofunctionalize/decorate bioinks with cell recognition sequences, it is important to keep in mind the ‘printability' of these novel materials. In this illustrated review, we define and refine the concept of ‘printability' and review seminal and contemporary studies to highlight the current ‘state of play' in the field with a focus on bioink composition and concentration, manipulation of nozzle parameters and rheological properties.
- 30 May 2017
- Published by Wiley in Advanced Healthcare Materials
- Vol. 6 (16)
Top Cited Papers‘Printability' of Candidate Biomaterials for Extrusion Based 3D Printing: State‐of‐the‐Art
Regenerative medicine has been highlighted as one of the UK's 8 ‘Great Technologies' with the potential to revolutionize patient care in the 21st Century. Over the last decade, the concept of ‘3D bioprinting' has emerged, which allows the precise deposition of cell laden bioinks with the aim of engineering complex, functional tissues. For 3D printing to be used clinically, there is the need to produce advanced functional biomaterials, a new generation of bioinks with suitable cell culture and high shape/print fidelity, to match or exceed the physical, chemical and biological properties of human tissue. With the rapid increase in knowledge associated with biomaterials, cell‐scaffold interactions and the ability to biofunctionalize/decorate bioinks with cell recognition sequences, it is important to keep in mind the ‘printability' of these novel materials. In this illustrated review, we define and refine the concept of ‘printability' and review seminal and contemporary studies to highlight the current ‘state of play' in the field with a focus on bioink composition and concentration, manipulation of nozzle parameters and rheological properties.